Scleroderma-related interstitial lung disease.

Authors

• Sally Suliman
• Abdalhamid Al Harash
• William Neil Roberts
• Rafael L Perez
• Jesse Roman

Publication/Presentation Date

1-1-2017

Abstract

Scleroderma-related interstitial lung disease (SSc-ILD) is a pulmonary fibrosing disorder characterized by systemic inflammation and progressive scarring of the lungs that leads to respiratory failure. Although certain immunosuppressive therapies may slow disease progression, current treatment strategies are not curative; consequently, SSc-ILD continues to be a major cause of morbidity and mortality. We present four cases of SSc-ILD that emphasize the importance of early screening and detection, close follow-up, and aggressive management. We also highlight the need for well-conducted clinical trials designed to identify new and effective treatments.

Volume

22

First Page

109

Last Page

112

ISSN

2213-0071

Published In/Presented At

Suliman, S., Al Harash, A., Roberts, W. N., Perez, R. L., & Roman, J. (2017). Scleroderma-related interstitial lung disease. Respiratory medicine case reports, 22, 109–112. https://doi.org/10.1016/j.rmcr.2017.07.007

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

28761806

Department(s)

Administration and Leadership

Document Type

Article